Literature DB >> 9561673

Do noninherited maternal antigens (NIMA) enhance renal graft survival?

J M Smits1, F H Claas, H C van Houwelingen, G G Persijn.   

Abstract

To test the hypothesis that noninherited maternal antigens (NIMA) can modulate the alloreactivity of infant cells and provide protection for renal transplant recipients, a study of renal transplantations performed between 1980 and 1991 was undertaken. The survival rate of grafts with a mismatched antigen identical to the NIMA was compared to that of grafts in which the mismatched antigen was not identical to the NIMA. In the case of HLA-A mismatches, graft survival rates were significantly better for NIMA-mismatched transplants: 94% and 83% at 1 and 3 years, respectively, for single NIMA HLA-A mismatched transplants, and 83% and 67% when both HLA-A antigens were mismatched, compared to 76% and 68% (one non NIMA HLA-A mismatch) and 67% and 45% (two non-NIMA HLA-A mismatches). Our results suggest that some class I NIMA-mismatched antigens are not harmful to renal transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561673     DOI: 10.1007/s001470050109

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Cellular therapies supplement: the peritoneum as an ectopic site of hematopoiesis following in utero transplantation.

Authors:  Marcus O Muench; Jeng-Chang Chen; Ashley I Beyer; Marina E Fomin
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  The pendulum swings: Tolerance versus priming to NIMA.

Authors:  Shannon J Opiela; Becky Adkins
Journal:  Chimerism       Date:  2010 Jul-Sep

3.  Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation?

Authors:  Tatsuo Ichinohe; Etsuko Maruya; Hiroh Saji
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

4.  The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.

Authors:  Julia Pingel; Tao Wang; Yvonne Hagenlocher; Camila J Hernández-Frederick; Arnon Nagler; Michael D Haagenson; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Stephanie J Lee; Mohamad Mohty; Emmanuelle Polge; Stephen R Spellman; Alexander H Schmidt; Jon J van Rood
Journal:  Bone Marrow Transplant       Date:  2018-10-02       Impact factor: 5.483

5.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

6.  Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA).

Authors:  M L Molitor-Dart; J Andrassy; L D Haynes; W J Burlingham
Journal:  Am J Transplant       Date:  2008-11       Impact factor: 8.086

7.  Cross-decoration of dendritic cells by non-inherited maternal antigen-containing extracellular vesicles: Potential mechanism for PD-L1-based tolerance in cord blood and organ transplantation.

Authors:  Diego A Lema; Ewa Jankowska-Gan; Ashita Nair; Sami B Kanaan; Christopher J Little; David P Foley; Afsar Raza Naqvi; Jianxin Wang; Seungpyo Hong; J Lee Nelson; David Al-Adra; William J Burlingham; Jeremy A Sullivan
Journal:  Am J Transplant       Date:  2022-03-15       Impact factor: 9.369

8.  Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.

Authors:  Roberta Rovito; Frans H J Claas; Geert W Haasnoot; Dave L Roelen; Aloys C M Kroes; Michael Eikmans; Ann C T M Vossen
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.